Unnati Pharmax

Aziderm Cream
Composition: Azelaic Acid 20% w/w
International Trade Name: Azelex®

Aziderm Cream is a premium Azelaic Acid 20% w/w topical dermatological formulation, therapeutically equivalent to the internationally recognized brand Azelex®. It is widely prescribed for the management of acne vulgaris, melasma, hyperpigmentation, and other pigmentary skin disorders, offering effective and well-tolerated results across diverse skin types.

Azelaic Acid is a naturally occurring dicarboxylic acid with antibacterial, anti-inflammatory, and comedolytic properties. It works by inhibiting the growth of acne-causing bacteria (Cutibacterium acnes), normalizing abnormal keratinization of hair follicles, and reducing inflammation. Additionally, Azelaic Acid suppresses tyrosinase activity, helping to reduce excess melanin production, making Aziderm Cream highly effective in melasma and post-inflammatory hyperpigmentation.

Primobolon 10ml Injection
Composition: Methenolone Enanthate Injection 10ml
International Trade Name: Primobolon®

Primobolon 10ml is a high-quality Methenolone Enanthate Injection, a long-acting anabolic steroid widely used for clinical applications requiring muscle preservation and anabolic support. Manufactured in WHO-GMP certified facilities, Primobolon Injection is supplied by trusted pharmaceutical exporters from India to support advanced therapeutic programs in muscle wasting, catabolic disorders, and recovery management.

Methenolone Enanthate is a mild anabolic-androgenic steroid (AAS) with low androgenic activity, promoting nitrogen retention, protein synthesis, and lean muscle mass without significant water retention. Primobolon 10ml Injection is primarily indicated for the treatment of catabolic states, severe weight loss, chronic illness, osteoporosis, and post-surgical or post-trauma recovery, especially in patients requiring safe anabolic support with minimal androgenic side effects.

Methenolone Enanthate injection, Primobolon injection, anabolic steroid injection, muscle wasting treatment, therapeutic steroid injection, injectable anabolic therapy, pharmaceutical exporter India, and hormonal therapy manufacturer India.

Primobolon 10ml Injection is manufactured under stringent GMP and pharmaceutical quality standards, ensuring consistent efficacy, safety, and long-term stability. The injection is supplied in secure, export-grade vials with complete regulatory documentation, making it suitable for hospitals, specialty clinics, rehabilitation centers, and international pharmaceutical distributors.

Viro 4 Kit Tablets (Tenolam-AR)
Composition: Tenofovir Disoproxil Fumarate + Lamivudine + Atazanavir + Ritonavir
International Trade Name: Tenolam-AR

Viro 4 Kit (Tenolam-AR) is a high-quality fixed-dose combination antiretroviral therapy (ART) tablet, therapeutically formulated for adults and adolescents living with HIV-1. Manufactured in WHO-GMP certified facilities, Tenolam-AR Tablets are supplied by trusted pharmaceutical exporters from India to support global HIV/AIDS treatment programs, offering a convenient, multi-drug regimen in a single kit to enhance patient adherence and treatment outcomes.

This combination includes Tenofovir Disoproxil Fumarate (TDF) and Lamivudine (3TC), both nucleoside/nucleotide reverse transcriptase inhibitors (NRTIs), together with Atazanavir and Ritonavir, which are protease inhibitors (PIs). Ritonavir functions as a pharmacokinetic booster to increase Atazanavir plasma concentrations. This combination effectively suppresses HIV viral replication, enhances CD4 counts, and reduces the risk of antiretroviral resistance.

Tenofovir Lamivudine Atazanavir Ritonavir tablets, Viro 4 Kit, Tenolam-AR tablet, fixed-dose combination ART, HIV treatment regimen, boosted protease inhibitor therapy, pharmaceutical exporter India, and antiretroviral manufacturer India.

Tenolam-AR Tablets are manufactured under stringent GMP and pharmaceutical quality standards, ensuring consistent potency, safety, and therapeutic efficacy. The tablets are supplied in secure, export-grade, tamper-proof packaging with complete regulatory documentation, making them suitable for hospitals, ART centers, government HIV programs, NGOs, and international pharmaceutical distributors worldwide.

Inbec Tablets
Composition: Abacavir, Dolutegravir & Lamivudine Tablets
International Trade Name: Triumeq®

Inbec is a high-quality fixed-dose combination tablet of Abacavir, Dolutegravir, and Lamivudine, a bioequivalent formulation of the internationally recognized antiretroviral medicine marketed under the brand name Triumeq®. Manufactured in WHO-GMP certified pharmaceutical facilities, Inbec Tablets are supplied by trusted pharmaceutical exporters from India to support global HIV/AIDS treatment programs, offering a convenient once-daily regimen that improves adherence and long-term treatment outcomes.

This combination brings together three potent antiretroviral agents: Abacavir (a nucleoside reverse transcriptase inhibitor), Dolutegravir (an integrase strand transfer inhibitor), and Lamivudine (a nucleoside reverse transcriptase inhibitor). Together, they act at different stages of the HIV replication cycle, providing rapid viral suppression and a high barrier to resistance. Inbec Tablets are primarily indicated for the treatment of HIV-1 infection in adults and adolescents, in accordance with national and international HIV treatment guidelines.

Abacavir Dolutegravir Lamivudine tablets, Inbec tablet, Triumeq generic, HIV single-tablet regimen, fixed-dose combination ART, integrase inhibitor–based HIV therapy, pharmaceutical exporter India, and antiretroviral manufacturer India.

Inbec Tablets are manufactured under stringent GMP and pharmaceutical quality standards, ensuring consistent potency, safety, and therapeutic efficacy. The tablets are supplied in secure, export-grade, tamper-proof packaging with complete regulatory and quality documentation, making them suitable for government HIV programs, hospitals, ART centers, global health initiatives, NGOs, and international pharmaceutical distributors worldwide.

Tacroz 0.1% Ointment
Composition: Tacrolimus Ointment 0.1% w/w
International Trade Name: Protopic®

Tacroz 0.1% is a high-quality Tacrolimus Ointment 0.1%, a bioequivalent formulation of the internationally recognized topical immunomodulator marketed under the brand name Protopic®. Manufactured in WHO-GMP certified pharmaceutical facilities, Tacroz Ointment is supplied by trusted pharmaceutical exporters from India to support advanced dermatology and immunology treatment programs worldwide.

Tacrolimus is a topical calcineurin inhibitor that works by suppressing T-cell activation and reducing inflammatory cytokine release in the skin. Unlike topical corticosteroids, it does not cause skin thinning, making Tacroz 0.1% Ointment especially suitable for long-term and sensitive-area use. It is primarily indicated for the treatment of moderate to severe atopic dermatitis (eczema) in adults who do not respond adequately to or cannot tolerate conventional therapies.

Tacrolimus 0.1% ointment, Tacroz ointment, Protopic generic, atopic dermatitis treatment, non-steroidal eczema therapy, dermatology ointment, pharmaceutical exporter India, and dermatology medicine manufacturer India.

Tacroz 0.1% Ointment is manufactured under stringent GMP and dermatological quality standards, ensuring consistent potency, safety, and skin tolerability. The product is supplied in secure, export-grade packaging with complete regulatory and quality documentation, making it suitable for dermatology clinics, hospitals, specialty pharmacies, government healthcare programs, and international pharmaceutical distributors worldwide.

Reatix-Kit Tablets
Composition: Atazanavir, Emtricitabine, Ritonavir & Tenofovir Disoproxil Fumarate Tablets
International Trade Name: Reyataz® / Truvada® / Norvir®

Reatix-Kit is a high-quality fixed-dose combination tablet containing Atazanavir, Emtricitabine, Ritonavir, and Tenofovir Disoproxil Fumarate, a bioequivalent formulation of the internationally recognized antiretroviral medicines Reyataz® (Atazanavir), Truvada® (Emtricitabine + Tenofovir), and Norvir® (Ritonavir). Manufactured in WHO-GMP certified pharmaceutical facilities, Reatix-Kit Tablets are supplied by trusted pharmaceutical exporters from India to support global HIV/AIDS treatment programs, providing a potent protease inhibitor–based combination therapy for adults and adolescents living with HIV-1.

Atazanavir is a protease inhibitor (PI) that inhibits HIV protease, preventing viral maturation. Ritonavir acts as a pharmacokinetic booster, increasing Atazanavir plasma levels and enhancing its therapeutic effect. Emtricitabine and Tenofovir Disoproxil Fumarate are nucleoside/nucleotide reverse transcriptase inhibitors (NRTI/NtRTI) that inhibit HIV reverse transcriptase, preventing viral replication. Together, this combination ensures potent viral suppression and reduces the risk of drug resistance.

Reatix-Kit Tablets are primarily indicated for the treatment of HIV-1 infection in adults and adolescents as part of combination antiretroviral therapy (ART), in accordance with national and international HIV treatment guidelines.

Atazanavir Emtricitabine Ritonavir Tenofovir tablets, Reatix-Kit tablet, Reyataz Truvada Norvir generic, fixed-dose combination ART, HIV protease inhibitor therapy, antiretroviral medicine, pharmaceutical exporter India, and antiretroviral manufacturer India.

Reatix-Kit Tablets are manufactured under stringent GMP and pharmaceutical quality standards, ensuring consistent potency, safety, and therapeutic efficacy. The tablets are supplied in secure, export-grade, tamper-proof packaging with complete regulatory and quality documentation, making them suitable for government HIV programs, hospitals, ART centers, NGOs, and international pharmaceutical distributors worldwide.

Abamune-L Tablets
Composition: Abacavir 600mg & Lamivudine 300mg Tablets
International Trade Name: Kivexa® / Epzicom®

Abamune-L is a high-quality fixed-dose combination tablet of Abacavir and Lamivudine, a bioequivalent formulation of the internationally recognized antiretroviral medicines Kivexa® and Epzicom®. Manufactured in WHO-GMP certified pharmaceutical facilities, Abamune-L Tablets are supplied by trusted pharmaceutical exporters from India to support global HIV/AIDS treatment programs, providing a convenient and effective dual NRTI regimen for adults and adolescents living with HIV-1.

This combination includes Abacavir and Lamivudine, both nucleoside reverse transcriptase inhibitors (NRTIs), which work by inhibiting HIV reverse transcriptase, preventing viral replication. Abamune-L Tablets are primarily indicated for the treatment of HIV-1 infection as part of combination antiretroviral therapy (ART), in accordance with national and international HIV treatment guidelines.

Abacavir Lamivudine tablets, Abamune-L tablet, Kivexa Epzicom generic, dual NRTI therapy, HIV single-tablet regimen, antiretroviral therapy, pharmaceutical exporter India, and antiretroviral manufacturer India.

Abamune-L Tablets are manufactured under stringent GMP and pharmaceutical quality standards, ensuring consistent potency, safety, and therapeutic efficacy. The tablets are supplied in secure, export-grade, tamper-proof packaging with complete regulatory and quality documentation, making them suitable for government HIV programs, hospitals, ART centers, NGOs, and international pharmaceutical distributors worldwide.

Axentri 150mg Tablets
Composition: Maraviroc 150mg
International Trade Name: Selzentry®

Axentri 150mg is a high-quality Maraviroc 150mg tablet, a bioequivalent formulation of the internationally recognized antiretroviral medicine Selzentry®. Manufactured in WHO-GMP certified facilities, Axentri Tablets are supplied by trusted pharmaceutical exporters from India to support global HIV/AIDS treatment programs, particularly for patients with CCR5-tropic HIV-1 infection.

Maraviroc is a CCR5 receptor antagonist that prevents HIV from entering and infecting human CD4+ cells by blocking the CCR5 co-receptor on the surface of T-cells. Axentri 150mg Tablets are primarily indicated for the treatment of CCR5-tropic HIV-1 infection in combination with other antiretroviral agents, for adults and adolescents, especially in treatment-experienced patients who require a novel mechanism of action.

Maraviroc 150mg tablets, Axentri tablet, Selzentry generic, CCR5 inhibitor, HIV entry inhibitor therapy, antiretroviral medicine, pharmaceutical exporter India, and antiretroviral manufacturer India.

Axentri 150mg Tablets are manufactured under stringent GMP and pharmaceutical quality standards, ensuring consistent potency, safety, and therapeutic efficacy. The tablets are supplied in secure, export-grade, tamper-proof packaging with complete regulatory documentation, making them suitable for hospitals, ART centers, government HIV programs, NGOs, and international pharmaceutical distributors worldwide.

Cmvee 450mg Tablets
Composition: Valganciclovir Tablets USP 450mg
International Trade Name: Valcyte®

Cmvee 450 is a high-quality Valganciclovir 450mg Tablet, a bioequivalent formulation of the internationally recognized antiviral medicine marketed under the brand name Valcyte®. Manufactured in WHO-GMP certified pharmaceutical facilities, Cmvee Tablets are supplied by trusted pharmaceutical exporters from India to support advanced antiviral therapy programs, particularly in transplant medicine and immunocompromised patient care.

Valganciclovir is an oral prodrug of ganciclovir that is rapidly converted in the body to its active form, effectively inhibiting viral DNA synthesis and preventing viral replication. Cmvee 450mg Tablets are primarily indicated for the treatment and prevention of cytomegalovirus (CMV) infections, including CMV retinitis in patients with AIDS and CMV prophylaxis in solid organ and hematopoietic stem cell transplant recipients, in accordance with established clinical guidelines.

Valganciclovir 450mg tablets, Cmvee 450 tablet, Valcyte generic, CMV treatment medicine, antiviral tablets for transplant patients, CMV prophylaxis drug, pharmaceutical exporter India, and antiviral manufacturer India.

Cmvee 450mg Tablets are manufactured under stringent GMP and pharmaceutical quality standards, ensuring consistent potency, safety, and therapeutic efficacy. The tablets are supplied in export-grade, tamper-proof packaging with complete regulatory and quality documentation, making them suitable for transplant centers, tertiary care hospitals, infectious disease clinics, government healthcare programs, and international pharmaceutical distributors worldwide.

VALGAN 450mg Tablets
Composition: Valganciclovir Tablets 450mg
International Trade Name: Valcyte®

VALGAN 450 is a high-quality Valganciclovir 450mg Tablet, a bioequivalent formulation of the internationally recognized antiviral medicine marketed under the brand name Valcyte®. Manufactured in WHO-GMP certified pharmaceutical facilities, VALGAN Tablets are supplied by trusted pharmaceutical exporters from India to support advanced antiviral therapy programs, particularly in transplant medicine and immunocompromised patient care.

Valganciclovir is an oral prodrug of ganciclovir that is rapidly converted in the body to its active form, where it inhibits viral DNA synthesis and prevents viral replication. VALGAN 450mg Tablets are primarily indicated for the treatment and prevention of cytomegalovirus (CMV) infections, including CMV retinitis in patients with AIDS and CMV prophylaxis in solid organ and hematopoietic stem cell transplant recipients, as per established clinical guidelines.

Valganciclovir 450mg tablets, VALGAN 450 tablet, Valcyte generic, CMV treatment medicine, antiviral tablets for transplant patients, CMV prophylaxis drug, pharmaceutical exporter India, and antiviral manufacturer India.

VALGAN 450mg Tablets are manufactured under stringent GMP and pharmaceutical quality standards, ensuring consistent potency, safety, and therapeutic efficacy. The tablets are supplied in export-grade, tamper-proof packaging with complete regulatory and quality documentation, making them suitable for transplant centers, tertiary care hospitals, infectious disease clinics, government healthcare programs, and international pharmaceutical distributors worldwide.

Viranz 600 Tablets
Composition: Efavirenz Tablets 600mg
International Trade Name: Sustiva®

Viranz 600 is a high-quality Efavirenz 600mg Tablet, a bioequivalent formulation of the internationally recognized antiretroviral medicine marketed under the brand name Sustiva®. Manufactured in WHO-GMP certified pharmaceutical facilities, Viranz Tablets are supplied by trusted pharmaceutical exporters from India to support global HIV/AIDS treatment and prevention programs, ensuring consistent access to essential antiretroviral therapy.

Efavirenz is a non-nucleoside reverse transcriptase inhibitor (NNRTI) that inhibits HIV-1 reverse transcriptase, thereby blocking viral replication and significantly reducing viral load. Viranz 600mg Tablets are primarily indicated for the treatment of HIV-1 infection in adults and adolescents, used as part of combination antiretroviral therapy (ART) in accordance with national and international HIV treatment guidelines.

Efavirenz 600mg tablets, Viranz 600 tablet, Sustiva generic, Efavirenz price, HIV antiviral medicine, NNRTI antiretroviral drug, HIV treatment tablets, pharmaceutical exporter India, and antiretroviral manufacturer India.

Viranz 600 Tablets are manufactured under stringent GMP and pharmaceutical quality standards, ensuring consistent potency, safety, and therapeutic efficacy. The tablets are supplied in export-grade, tamper-proof packaging with complete regulatory and quality documentation, making them suitable for government HIV programs, hospitals, ART centers, NGOs, global health initiatives, and international pharmaceutical distributors worldwide.

Valchek 450mg Tablets
Composition: Valganciclovir Hydrochloride Tablets 450mg
International Trade Name: Valcyte®

Valchek 450 is a high-quality Valganciclovir Hydrochloride 450mg Tablet, a bioequivalent formulation of the internationally recognized antiviral medicine marketed under the brand name Valcyte®. Manufactured in WHO-GMP certified pharmaceutical facilities, Valchek Tablets are supplied by trusted pharmaceutical exporters from India to support advanced antiviral therapy programs, particularly in transplant medicine and immunocompromised patient care.

Valganciclovir hydrochloride is an oral prodrug of ganciclovir that is rapidly converted in the body to its active form, effectively inhibiting viral DNA synthesis and preventing viral replication. Valchek 450mg Tablets are primarily indicated for the treatment and prevention of cytomegalovirus (CMV) infections, including CMV retinitis in patients with AIDS and CMV prophylaxis in solid organ and hematopoietic stem cell transplant recipients, in accordance with established clinical guidelines.

Valganciclovir hydrochloride 450mg tablets, Valchek 450 tablet, Valcyte generic, CMV treatment medicine, antiviral tablets for transplant patients, CMV prophylaxis drug, pharmaceutical exporter India, and antiviral manufacturer India.

Valchek 450mg Tablets are manufactured under stringent GMP and pharmaceutical quality standards, ensuring consistent potency, safety, and therapeutic efficacy. The tablets are supplied in export-grade, tamper-proof packaging with complete regulatory and quality documentation, making them suitable for transplant centers, tertiary care hospitals, infectious disease clinics, government healthcare programs, and international pharmaceutical distributors worldwide.

Hiataz-R Tablets
Composition: Atazanavir & Ritonavir Tablets
International Trade Name: Reyataz® / Hiataz-R

Hiataz-R is a high-quality fixed-dose combination tablet of Atazanavir and Ritonavir, a bioequivalent formulation of the internationally recognized antiretroviral medicine Reyataz®. Manufactured in WHO-GMP certified pharmaceutical facilities, Hiataz-R Tablets are supplied by trusted pharmaceutical exporters from India to support global HIV/AIDS treatment programs, providing an effective protease inhibitor–based therapy for adults and adolescents living with HIV-1.

Atazanavir is a protease inhibitor (PI) that inhibits HIV protease, preventing viral maturation and reducing viral replication. Ritonavir acts as a pharmacokinetic booster by inhibiting CYP3A enzymes, increasing Atazanavir plasma levels and prolonging its therapeutic effect. Hiataz-R Tablets are primarily indicated for the treatment of HIV-1 infection in combination with other antiretroviral agents, following national and international HIV treatment guidelines.

Atazanavir Ritonavir tablets, Hiataz-R tablet, Reyataz generic, boosted protease inhibitor therapy, HIV protease inhibitor regimen, antiretroviral medicine, pharmaceutical exporter India, and antiretroviral manufacturer India.

Hiataz-R Tablets are manufactured under stringent GMP and pharmaceutical quality standards, ensuring consistent potency, safety, and therapeutic efficacy. The tablets are supplied in secure, export-grade, tamper-proof packaging with complete regulatory and quality documentation, making them suitable for government HIV programs, hospitals, ART centers, NGOs, and international pharmaceutical distributors worldwide.

Lavir 150mg Tablets
Composition: Lamivudine Tablets 150mg
International Trade Name: Epivir®

Lavir 150 is a high-quality Lamivudine 150mg Tablet, a bioequivalent formulation of the internationally recognized antiviral medicine marketed under the brand name Epivir®. Manufactured in WHO-GMP certified pharmaceutical facilities, Lavir Tablets are supplied by trusted pharmaceutical exporters from India to support global HIV and chronic hepatitis B treatment programs, ensuring reliable access to essential antiviral therapy.

Lamivudine is a nucleoside reverse transcriptase inhibitor (NRTI) that inhibits viral DNA synthesis, thereby reducing viral replication. Lavir 150mg Tablets are primarily indicated for the treatment of HIV-1 infection as part of combination antiretroviral therapy (ART), and for the management of chronic hepatitis B virus (HBV) infection, in accordance with national and international treatment guidelines.

Lamivudine 150mg tablets, Lavir 150 tablet, Epivir generic, HIV antiviral medicine, hepatitis B treatment tablets, NRTI antiretroviral drug, pharmaceutical exporter India, and antiviral manufacturer India.

Lavir 150mg Tablets are manufactured under stringent GMP and pharmaceutical quality standards, ensuring consistent potency, safety, and therapeutic efficacy. The tablets are supplied in export-grade, tamper-proof packaging with complete regulatory and quality documentation, making them suitable for government HIV programs, hospitals, ART centers, hepatitis clinics, NGOs, and international pharmaceutical distributors worldwide.

Atazor 200mg Capsules
Composition: Atazanavir 200mg Capsule
International Trade Name: Reyataz®

Atazor 200mg is a high-quality Atazanavir 200mg Capsule, a bioequivalent formulation of the internationally recognized antiretroviral medicine marketed under the brand name Reyataz®. Manufactured in WHO-GMP certified pharmaceutical facilities, Atazor Capsules are supplied by trusted pharmaceutical exporters from India to support global HIV/AIDS treatment programs, providing an effective protease inhibitor–based therapy for adults and adolescents living with HIV-1.

Atazanavir is a protease inhibitor (PI) that inhibits HIV protease, preventing viral maturation and reducing viral replication. Atazor 200mg Capsules are primarily indicated for the treatment of HIV-1 infection in combination with other antiretroviral agents, following national and international HIV treatment guidelines.

Atazanavir 200mg capsules, Atazor 200 capsule, Reyataz generic, HIV protease inhibitor therapy, boosted PI regimen, antiretroviral medicine, pharmaceutical exporter India, and antiretroviral manufacturer India.

Atazor 200mg Capsules are manufactured under stringent GMP and pharmaceutical quality standards, ensuring consistent potency, safety, and therapeutic efficacy. The capsules are supplied in secure, export-grade, tamper-proof packaging with complete regulatory and quality documentation, making them suitable for government HIV programs, hospitals, ART centers, NGOs, and international pharmaceutical distributors worldwide.

Efcure 600mg Tablets
Composition: Efavirenz Tablets 600mg
International Trade Name: Sustiva®

Efcure 600 is a high-quality Efavirenz 600mg Tablet, a bioequivalent formulation of the internationally recognized antiretroviral medicine marketed under the brand name Sustiva®. Manufactured in WHO-GMP certified pharmaceutical facilities, Efcure Tablets are supplied by trusted pharmaceutical exporters from India to support global HIV/AIDS treatment and prevention programs, ensuring consistent access to essential antiretroviral therapy.

Efavirenz is a non-nucleoside reverse transcriptase inhibitor (NNRTI) that works by inhibiting the HIV-1 reverse transcriptase enzyme, thereby preventing viral replication and significantly reducing viral load. Efcure 600mg Tablets are primarily indicated for the treatment of HIV-1 infection in adults and adolescents, used as part of combination antiretroviral therapy (ART) in accordance with national and international HIV treatment guidelines.

Efavirenz 600mg tablets, Efcure 600 tablet, Sustiva generic, Efavirenz price, HIV antiviral medicine, NNRTI antiretroviral drug, HIV treatment tablets, pharmaceutical exporter India, and antiretroviral manufacturer India.

Efcure 600mg Tablets are manufactured under stringent GMP and pharmaceutical quality standards, ensuring consistent potency, safety, and therapeutic efficacy. The tablets are supplied in export-grade, tamper-proof packaging with complete regulatory and quality documentation, making them suitable for government HIV programs, hospitals, ART centers, NGOs, global health initiatives, and international pharmaceutical distributors worldwide.

Valnova 450mg Tablets
Composition: Valganciclovir Tablets 450mg
International Trade Name: Valcyte®

Valnova 450 is a high-quality Valganciclovir 450mg Tablet, a bioequivalent formulation of the internationally recognized antiviral medicine marketed under the brand name Valcyte®. Manufactured in WHO-GMP certified pharmaceutical facilities, Valnova Tablets are supplied by trusted pharmaceutical exporters from India to support advanced antiviral therapy programs, particularly in transplant medicine and immunocompromised patient care.

Valganciclovir is an oral prodrug of ganciclovir that is rapidly converted in the body to its active form, effectively inhibiting viral DNA synthesis. Valnova 450mg Tablets are primarily indicated for the treatment and prevention of cytomegalovirus (CMV) infections, including CMV retinitis in patients with AIDS and CMV prophylaxis in solid organ and hematopoietic stem cell transplant recipients, as per established clinical guidelines.

Valganciclovir 450mg tablets, Valnova 450 tablet, Valcyte generic, CMV treatment medicine, antiviral tablets for transplant patients, CMV prophylaxis drug, pharmaceutical exporter India, and antiviral manufacturer India.

Valnova 450mg Tablets are manufactured under stringent GMP and pharmaceutical quality standards, ensuring consistent potency, safety, and therapeutic efficacy. The tablets are supplied in export-grade, tamper-proof packaging with complete regulatory and quality documentation, making them suitable for transplant centers, tertiary care hospitals, infectious disease clinics, government healthcare programs, and international pharmaceutical distributors worldwide.

Danavir-R Tablets
Composition: Darunavir & Ritonavir Tablets 600mg
International Trade Name: Prezista® & Norvir®

Danavir-R is a high-quality fixed-dose combination tablet of Darunavir and Ritonavir, a bioequivalent formulation of the internationally recognized antiretroviral medicines Prezista® (Darunavir) and Norvir® (Ritonavir). Manufactured in WHO-GMP certified pharmaceutical facilities, Danavir-R Tablets are supplied by trusted pharmaceutical exporters from India to support global HIV/AIDS treatment programs, providing an effective protease inhibitor–based therapy for adults and adolescents living with HIV-1.

Darunavir is a protease inhibitor (PI) that inhibits HIV protease, preventing viral maturation and reducing viral replication. Ritonavir acts as a pharmacokinetic booster by inhibiting CYP3A enzymes, increasing Darunavir plasma levels and enhancing its therapeutic effect. Danavir-R Tablets are primarily indicated for the treatment of HIV-1 infection in combination with other antiretroviral agents, as per national and international HIV treatment guidelines.

Darunavir Ritonavir tablets, Danavir-R tablet, Prezista Norvir generic, HIV protease inhibitor therapy, boosted PI regimen, HIV antiviral medicine, pharmaceutical exporter India, and antiretroviral manufacturer India.

Danavir-R Tablets are manufactured under stringent GMP and pharmaceutical quality standards, ensuring consistent potency, safety, and therapeutic efficacy. The tablets are supplied in export-grade, tamper-proof packaging with complete regulatory and quality documentation, making them suitable for government HIV programs, hospitals, ART centers, NGOs, and international pharmaceutical distributors worldwide.

Emletra Tablets
Composition: Lopinavir & Ritonavir Tablets
International Trade Name: Kaletra®

Emletra is a high-quality fixed-dose combination of Lopinavir and Ritonavir, a bioequivalent formulation of the internationally recognized antiretroviral medicine marketed under the brand name Kaletra®. Manufactured in WHO-GMP certified pharmaceutical facilities, Emletra Tablets are supplied by trusted pharmaceutical exporters from India to support global HIV/AIDS treatment programs, offering effective protease inhibitor–based therapy for adults and adolescents living with HIV-1.

Lopinavir is a protease inhibitor (PI) that prevents the maturation of viral particles by inhibiting HIV protease, thereby reducing viral replication. Ritonavir acts as a pharmacokinetic enhancer by inhibiting CYP3A enzymes, boosting Lopinavir plasma concentrations and prolonging its therapeutic effect. Emletra Tablets are primarily indicated for the treatment of HIV-1 infection in combination with other antiretroviral agents, in line with national and international HIV treatment guidelines.

Lopinavir Ritonavir tablets, Emletra tablet, Kaletra generic, HIV protease inhibitor therapy, boosted PI regimen, antiretroviral medicine, pharmaceutical exporter India, and antiretroviral manufacturer India.

Emletra Tablets are manufactured under stringent GMP and pharmaceutical quality standards, ensuring consistent potency, safety, and therapeutic efficacy. The tablets are supplied in secure, export-grade, tamper-proof packaging with complete regulatory and quality documentation, making them suitable for government HIV programs, hospitals, ART centers, NGOs, and international pharmaceutical distributors worldwide.

Alltera Tablets
Composition: Lopinavir 200mg & Ritonavir 50mg Tablets
International Trade Name: Kaletra®

Alltera is a high-quality fixed-dose combination tablet of Lopinavir and Ritonavir, a bioequivalent formulation of the internationally recognized antiretroviral medicine marketed under the brand name Kaletra®. Manufactured in WHO-GMP certified pharmaceutical facilities, Alltera Tablets are supplied by trusted pharmaceutical exporters from India to support global HIV/AIDS treatment programs, offering an effective protease inhibitor–based therapy for adults and adolescents living with HIV-1.

Lopinavir is a protease inhibitor (PI) that blocks HIV protease activity, preventing the maturation of viral particles and reducing viral load. Ritonavir acts as a pharmacokinetic enhancer by inhibiting CYP3A enzymes, thereby boosting Lopinavir plasma concentrations and prolonging its therapeutic effect. Alltera 200mg/50mg Tablets are primarily indicated for the treatment of HIV-1 infection in combination with other antiretroviral agents, following national and international HIV treatment guidelines.

Lopinavir Ritonavir tablets, Alltera tablet, Kaletra generic, HIV protease inhibitor therapy, boosted PI regimen, antiretroviral medicine, pharmaceutical exporter India, and antiretroviral manufacturer India.

Alltera Tablets are manufactured under stringent GMP and pharmaceutical quality standards, ensuring consistent potency, safety, and therapeutic efficacy. The tablets are supplied in secure, export-grade, tamper-proof packaging with complete regulatory and quality documentation, making them suitable for government HIV programs, hospitals, ART centers, NGOs, and international pharmaceutical distributors worldwide.

Efcure 200mg Tablets
Composition: Efavirenz Tablets 200mg
International Trade Name: Sustiva®

Efcure 200 is a high-quality Efavirenz 200mg Tablet, a bioequivalent formulation of the internationally recognized antiretroviral medicine marketed under the brand name Sustiva®. Manufactured in WHO-GMP certified pharmaceutical facilities, Efcure Tablets are supplied by trusted pharmaceutical exporters from India to support global HIV/AIDS treatment and prevention programs, ensuring reliable access to essential antiretroviral therapy.

Efavirenz is a non-nucleoside reverse transcriptase inhibitor (NNRTI) that inhibits HIV-1 reverse transcriptase, thereby preventing viral replication and reducing viral load. Efcure 200mg Tablets are primarily indicated for the treatment of HIV-1 infection in adults and pediatric patients, used as part of combination antiretroviral therapy (ART) in accordance with national and international HIV treatment guidelines.

Efavirenz 200mg tablets, Efcure 200 tablet, Sustiva generic, Efavirenz price, HIV antiviral medicine, NNRTI antiretroviral drug, HIV treatment tablets, pharmaceutical exporter India, and antiretroviral manufacturer India.

Efcure 200mg Tablets are manufactured under stringent GMP and pharmaceutical quality standards, ensuring consistent potency, safety, and therapeutic efficacy. The tablets are supplied in export-grade, tamper-proof packaging with complete regulatory and quality documentation, making them suitable for government HIV programs, hospitals, ART centers, NGOs, pediatric HIV care programs, and international pharmaceutical distributors worldwide.

Duovir Tablets
Composition: Lamivudine & Zidovudine Tablets IP
International Trade Name: Combivir® / Duovir®

Duovir is a high-quality fixed-dose combination tablet of Lamivudine and Zidovudine, a bioequivalent formulation of the internationally recognized antiretroviral medicines Epivir® (Lamivudine) and Retrovir® (Zidovudine), marketed as Combivir® globally. Manufactured in WHO-GMP certified pharmaceutical facilities, Duovir Tablets are supplied by trusted pharmaceutical exporters from India to support global HIV/AIDS treatment programs, offering a safe and effective dual NRTI regimen for adults and adolescents living with HIV-1.

Lamivudine and Zidovudine are nucleoside reverse transcriptase inhibitors (NRTIs) that inhibit HIV reverse transcriptase, preventing viral replication and reducing viral load. Duovir Tablets are primarily indicated for the treatment of HIV-1 infection, used as part of combination antiretroviral therapy (ART) in accordance with national and international HIV treatment guidelines.

Lamivudine Zidovudine tablets, Duovir tablet, Combivir generic, dual NRTI therapy, HIV treatment tablets, antiretroviral medicine, pharmaceutical exporter India, and antiretroviral manufacturer India.

Duovir Tablets are manufactured under stringent GMP and pharmaceutical quality standards, ensuring consistent potency, safety, and therapeutic efficacy. The tablets are supplied in secure, export-grade, tamper-proof packaging with complete regulatory and quality documentation, making them suitable for government HIV programs, hospitals, ART centers, NGOs, and international pharmaceutical distributors worldwide.

Lazid-N Tablets
Composition: Zidovudine, Lamivudine & Nevirapine Tablets
International Trade Name: Combivir® / Viramune®

Lazid-N is a high-quality fixed-dose combination tablet of Zidovudine, Lamivudine, and Nevirapine, a bioequivalent formulation of the internationally recognized antiretroviral medicines Combivir® (Zidovudine + Lamivudine) and Viramune® (Nevirapine). Manufactured in WHO-GMP certified pharmaceutical facilities, Lazid-N Tablets are supplied by trusted pharmaceutical exporters from India to support global HIV/AIDS treatment programs, providing an effective triple-drug regimen for adults and adolescents living with HIV-1.

This combination includes Zidovudine and Lamivudine (nucleoside reverse transcriptase inhibitors, NRTIs) and Nevirapine (a non-nucleoside reverse transcriptase inhibitor, NNRTI). By targeting multiple stages of HIV replication, Lazid-N Tablets ensure effective viral suppression and help reduce the risk of drug resistance. They are primarily indicated for the treatment of HIV-1 infection as part of combination antiretroviral therapy (ART), following national and international HIV treatment guidelines.

Zidovudine Lamivudine Nevirapine tablets, Lazid-N tablet, Combivir Viramune generic, fixed-dose combination ART, HIV single-tablet regimen, antiretroviral therapy, pharmaceutical exporter India, and antiretroviral manufacturer India.

Lazid-N Tablets are manufactured under stringent GMP and pharmaceutical quality standards, ensuring consistent potency, safety, and therapeutic efficacy. The tablets are supplied in secure, export-grade, tamper-proof packaging with complete regulatory and quality documentation, making them suitable for government HIV programs, hospitals, ART centers, NGOs, and international pharmaceutical distributors worldwide.

Danavir-R 800/100 Tablets
Composition: Darunavir 800mg & Ritonavir 100mg Tablets
International Trade Name: Prezista® & Norvir®

Danavir-R 800/100 is a high-quality fixed-dose combination tablet of Darunavir and Ritonavir, a bioequivalent formulation of the internationally recognized antiretroviral medicines Prezista® (Darunavir) and Norvir® (Ritonavir). Manufactured in WHO-GMP certified pharmaceutical facilities, Danavir-R Tablets are supplied by trusted pharmaceutical exporters from India to support global HIV/AIDS treatment programs, providing an effective protease inhibitor–based therapy for adults and adolescents living with HIV-1.

Darunavir is a protease inhibitor (PI) that inhibits HIV protease, preventing viral maturation and reducing viral replication. Ritonavir acts as a pharmacokinetic booster by inhibiting CYP3A enzymes, increasing Darunavir plasma levels and enhancing its therapeutic effect. Danavir-R Tablets are primarily indicated for the treatment of HIV-1 infection in combination with other antiretroviral agents, as per national and international HIV treatment guidelines.

Darunavir Ritonavir tablets, Danavir-R 800/100 tablet, Prezista Norvir generic, HIV protease inhibitor therapy, boosted PI regimen, antiretroviral medicine, pharmaceutical exporter India, and antiretroviral manufacturer India.

Danavir-R 800/100 Tablets are manufactured under stringent GMP and pharmaceutical quality standards, ensuring consistent potency, safety, and therapeutic efficacy. The tablets are supplied in secure, export-grade, tamper-proof packaging with complete regulatory and quality documentation, making them suitable for government HIV programs, hospitals, ART centers, NGOs, and international pharmaceutical distributors worldwide.

Ritocom Tablets
Composition: Lopinavir & Ritonavir Tablets
International Trade Name: Kaletra®

Ritocom is a high-quality fixed-dose combination tablet of Lopinavir and Ritonavir, a bioequivalent formulation of the internationally recognized antiretroviral medicine marketed under the brand name Kaletra®. Manufactured in WHO-GMP certified pharmaceutical facilities, Ritocom Tablets are supplied by trusted pharmaceutical exporters from India to support global HIV/AIDS treatment programs, providing an effective protease inhibitor–based therapy for adults and adolescents living with HIV-1.

Lopinavir is a protease inhibitor (PI) that inhibits HIV protease, preventing viral maturation and reducing viral replication. Ritonavir acts as a pharmacokinetic booster by inhibiting CYP3A enzymes, increasing Lopinavir plasma levels and enhancing its therapeutic effect. Ritocom Tablets are primarily indicated for the treatment of HIV-1 infection in combination with other antiretroviral agents, following national and international HIV treatment guidelines.

Lopinavir Ritonavir tablets, Ritocom tablet, Kaletra generic, HIV protease inhibitor therapy, boosted PI regimen, antiretroviral medicine, pharmaceutical exporter India, and antiretroviral manufacturer India.

Ritocom Tablets are manufactured under stringent GMP and pharmaceutical quality standards, ensuring consistent potency, safety, and therapeutic efficacy. The tablets are supplied in secure, export-grade, tamper-proof packaging with complete regulatory and quality documentation, making them suitable for government HIV programs, hospitals, ART centers, NGOs, and international pharmaceutical distributors worldwide.

Valgacel 450mg Tablets
Composition: Valganciclovir Tablets USP 450mg
International Trade Name: Valcyte®

Valgacel 450 is a high-quality Valganciclovir 450mg Tablet, a bioequivalent formulation of the internationally recognized antiviral medicine marketed under the brand name Valcyte®. Manufactured in WHO-GMP certified pharmaceutical facilities, Valgacel Tablets are supplied by trusted pharmaceutical exporters from India to support advanced antiviral therapy programs, particularly in transplant medicine and immunocompromised patient care.

Valganciclovir is an oral prodrug of ganciclovir that is rapidly converted in the body to its active form, effectively inhibiting viral DNA synthesis and preventing viral replication. Valgacel 450mg Tablets are primarily indicated for the treatment and prevention of cytomegalovirus (CMV) infections, including CMV retinitis in patients with AIDS, and CMV prophylaxis in solid organ and hematopoietic stem cell transplant recipients, in accordance with established clinical guidelines.

Valganciclovir 450mg tablets, Valgacel 450 tablet, Valcyte generic, CMV treatment medicine, antiviral tablets for transplant patients, CMV prophylaxis drug, pharmaceutical exporter India, and antiviral manufacturer India.

Valgacel 450mg Tablets are manufactured under stringent GMP and pharmaceutical quality standards, ensuring consistent potency, safety, and therapeutic efficacy. The tablets are supplied in export-grade, tamper-proof packaging with complete regulatory and quality documentation, making them suitable for transplant centers, tertiary care hospitals, infectious disease clinics, government healthcare programs, and international pharmaceutical distributors worldwide.

Emduo Tablets
Composition: Stavudine & Lamivudine Tablets
International Trade Name: Epivir® (Lamivudine)

Emduo is a high-quality fixed-dose combination tablet of Stavudine and Lamivudine, a bioequivalent formulation of the internationally recognized antiretroviral medicine Epivir® (Lamivudine). Manufactured in WHO-GMP certified pharmaceutical facilities, Emduo Tablets are supplied by trusted pharmaceutical exporters from India to support global HIV/AIDS treatment programs, offering an effective dual nucleoside reverse transcriptase inhibitor (NRTI) regimen for adults and adolescents living with HIV-

Stavudine and Lamivudine are both nucleoside reverse transcriptase inhibitors (NRTIs) that inhibit the HIV reverse transcriptase enzyme, preventing viral replication and reducing viral load. Emduo Tablets are primarily indicated for the treatment of HIV-1 infection, used as part of combination antiretroviral therapy (ART) in accordance with national and international HIV treatment guidelines.

Stavudine Lamivudine tablets, Emduo tablet, Epivir generic, dual NRTI therapy, HIV treatment tablets, antiretroviral medicine, pharmaceutical exporter India, and antiretroviral manufacturer India.

Emduo Tablets are manufactured under stringent GMP and pharmaceutical quality standards, ensuring consistent potency, safety, and therapeutic efficacy. The tablets are supplied in secure, export-grade, tamper-proof packaging with complete regulatory and quality documentation, making them suitable for government HIV programs, hospitals, ART centers, NGOs, and international pharmaceutical distributors worldwide.

Daruvir-R Tablets
Composition: Darunavir & Ritonavir Tablets 600mg
International Trade Name: Prezista® & Norvir®

Daruvir-R is a high-quality fixed-dose combination of Darunavir and Ritonavir, a bioequivalent formulation aligned with the internationally recognized antiretroviral medicines Prezista® (Darunavir) and Norvir® (Ritonavir). Manufactured in WHO-GMP certified pharmaceutical facilities, Daruvir-R Tablets are supplied by trusted pharmaceutical exporters from India to support global HIV/AIDS treatment programs, particularly for patients requiring protease inhibitor–based therapy.

Darunavir is a protease inhibitor (PI) that prevents the cleavage of viral polyproteins, resulting in the production of immature, non-infectious HIV particles. Ritonavir acts as a pharmacokinetic booster by inhibiting CYP3A enzymes, thereby increasing and sustaining therapeutic Darunavir plasma levels. Daruvir-R Tablets are primarily indicated for the treatment of HIV-1 infection in adults and adolescents, used in combination with other antiretroviral agents as per national and international HIV treatment guidelines.

Darunavir Ritonavir tablets, Daruvir-R tablet, Prezista Norvir generic, HIV protease inhibitor therapy, boosted PI regimen, HIV antiviral medicine, pharmaceutical exporter India, and antiretroviral manufacturer India.

Daruvir-R Tablets are manufactured under stringent GMP and pharmaceutical quality standards, ensuring consistent potency, safety, and therapeutic efficacy. The tablets are supplied in secure, export-grade, tamper-proof packaging with complete regulatory and quality documentation, making them suitable for government HIV programs, hospitals, ART centers, infectious disease clinics, NGOs, and international pharmaceutical distributors worldwide.

Zidine 300mg Tablets
Composition: Zidovudine 300mg Tablet
International Trade Name: Retrovir®

Zidine 300mg is a high-quality Zidovudine 300mg Tablet, a bioequivalent formulation of the internationally recognized antiretroviral medicine marketed under the brand name Retrovir®. Manufactured in WHO-GMP certified pharmaceutical facilities, Zidine Tablets are supplied by trusted pharmaceutical exporters from India to support global HIV/AIDS treatment programs, providing an effective nucleoside reverse transcriptase inhibitor (NRTI) therapy for adults and adolescents living with HIV-1.

Zidovudine is a nucleoside reverse transcriptase inhibitor (NRTI) that inhibits HIV reverse transcriptase, preventing viral replication and reducing viral load. Zidine 300mg Tablets are primarily indicated for the treatment of HIV-1 infection, often used as part of combination antiretroviral therapy (ART), in accordance with national and international HIV treatment guidelines.

Zidovudine 300mg tablets, Zidine 300 tablet, Retrovir generic, NRTI antiretroviral therapy, HIV treatment tablets, antiretroviral medicine, pharmaceutical exporter India, and antiretroviral manufacturer India.

Zidine 300mg Tablets are manufactured under stringent GMP and pharmaceutical quality standards, ensuring consistent potency, safety, and therapeutic efficacy. The tablets are supplied in secure, export-grade, tamper-proof packaging with complete regulatory and quality documentation, making them suitable for government HIV programs, hospitals, ART centers, NGOs, and international pharmaceutical distributors worldwide.

Nevilast-40 Tablets
Composition: Nevirapine, Lamivudine & Stavudine Tablets
International Trade Name: Triomune®

Nevilast-40 is a high-quality fixed-dose combination tablet of Nevirapine, Lamivudine, and Stavudine, a bioequivalent formulation of the internationally recognized antiretroviral medicines Triomune®. Manufactured in WHO-GMP certified pharmaceutical facilities, Nevilast-40 Tablets are supplied by trusted pharmaceutical exporters from India to support global HIV/AIDS treatment programs, providing a convenient and effective triple-drug regimen for adults and adolescents living with HIV-1.

This combination includes Nevirapine (a non-nucleoside reverse transcriptase inhibitor, NNRTI) and Lamivudine and Stavudine (nucleoside reverse transcriptase inhibitors, NRTIs). By targeting multiple stages of HIV replication, Nevilast-40 Tablets ensure effective viral suppression, reduce the risk of drug resistance, and simplify treatment with a single-tablet regimen.

Nevirapine Lamivudine Stavudine tablets, Nevilast-40 tablet, Triomune generic, fixed-dose combination ART, HIV single-tablet regimen, NRTI/NNRTI antiretroviral therapy, pharmaceutical exporter India, and antiretroviral manufacturer India.

Nevilast-40 Tablets are manufactured under stringent GMP and pharmaceutical quality standards, ensuring consistent potency, safety, and therapeutic efficacy. The tablets are supplied in secure, export-grade, tamper-proof packaging with complete regulatory and quality documentation, making them suitable for government HIV programs, hospitals, ART centers, NGOs, and international pharmaceutical distributors worldwide.

Heptavir 100mg Tablets
Composition: Lamivudine Tablets 100mg
International Trade Name: Epivir®

Heptavir 100 is a high-quality Lamivudine 100mg Tablet, a bioequivalent formulation of the internationally recognized antiviral medicine marketed under the brand name Epivir®. Manufactured in WHO-GMP certified pharmaceutical facilities, Heptavir Tablets are supplied by trusted pharmaceutical exporters from India to support global HIV and chronic hepatitis B treatment programs, ensuring safe and effective antiviral therapy.

Lamivudine is a nucleoside reverse transcriptase inhibitor (NRTI) that inhibits viral DNA synthesis, thereby preventing viral replication. Heptavir 100mg Tablets are primarily indicated for the treatment of HIV-1 infection as part of combination antiretroviral therapy (ART), and for the management of chronic hepatitis B virus (HBV) infection, in accordance with national and international treatment guidelines.

Lamivudine 100mg tablets, Heptavir 100 tablet, Epivir generic, NRTI antiretroviral therapy, HBV treatment tablets, HIV antiviral medicine, pharmaceutical exporter India, and antiviral manufacturer India.

Heptavir 100mg Tablets are manufactured under stringent GMP and pharmaceutical quality standards, ensuring consistent potency, safety, and therapeutic efficacy. The tablets are supplied in export-grade, tamper-proof packaging with complete regulatory and quality documentation, making them suitable for hospitals, ART centers, hepatitis clinics, government healthcare programs, NGOs, and international pharmaceutical distributors worldwide.

Abakast-L Tablets
Composition: Abacavir 600mg & Lamivudine 300mg Tablets
International Trade Name: Kivexa®

Abakast-L is a high-quality fixed-dose combination of Abacavir 600mg and Lamivudine 300mg, a bioequivalent formulation of the internationally recognized antiretroviral medicine marketed under the brand name Kivexa®. Manufactured in WHO-GMP certified pharmaceutical facilities, Abakast-L Tablets are supplied by trusted pharmaceutical exporters from India to support global HIV/AIDS treatment programs, offering a convenient once-daily regimen to enhance patient adherence and long-term therapeutic outcomes.

This combination includes Abacavir and Lamivudine, both of which are nucleoside reverse transcriptase inhibitors (NRTIs) that work by inhibiting viral reverse transcriptase and preventing HIV replication. Abakast-L Tablets are primarily indicated for the treatment of HIV-1 infection in adults and adolescents, as part of combination antiretroviral therapy (ART) following national and international HIV treatment guidelines.

Abacavir Lamivudine tablets, Abakast-L tablet, Kivexa generic, fixed-dose combination ART, HIV single-tablet regimen, NRTI antiretroviral therapy, pharmaceutical exporter India, and antiretroviral manufacturer India.

Abakast-L Tablets are manufactured under stringent GMP and pharmaceutical quality standards, ensuring consistent potency, safety, and therapeutic efficacy. The tablets are supplied in export-grade, tamper-proof packaging with complete regulatory and quality documentation, making them suitable for government HIV programs, hospitals, ART centers, NGOs, and international pharmaceutical distributors worldwide.

Abamune Tablets
Composition: Abacavir Sulphate Tablets
International Trade Name: Ziagen®

Abamune is a high-quality Abacavir Sulphate Tablet, a bioequivalent formulation of the internationally recognized antiretroviral medicine marketed under the brand name Ziagen®. Manufactured in WHO-GMP certified pharmaceutical facilities, Abamune Tablets are supplied by trusted pharmaceutical exporters from India to support global HIV/AIDS treatment programs, providing an effective nucleoside reverse transcriptase inhibitor (NRTI) therapy for adults and adolescents living with HIV-1.

Abacavir is a nucleoside reverse transcriptase inhibitor (NRTI) that inhibits HIV reverse transcriptase, preventing viral replication. Abamune Tablets are primarily indicated for the treatment of HIV-1 infection, often used as part of combination antiretroviral therapy (ART), in accordance with national and international HIV treatment guidelines.

Abacavir Sulphate tablets, Abamune tablet, Ziagen generic, NRTI antiretroviral therapy, HIV treatment tablets, antiretroviral medicine, pharmaceutical exporter India, and antiretroviral manufacturer India.

Abamune Tablets are manufactured under stringent GMP and pharmaceutical quality standards, ensuring consistent potency, safety, and therapeutic efficacy. The tablets are supplied in secure, export-grade, tamper-proof packaging with complete regulatory and quality documentation, making them suitable for government HIV programs, hospitals, ART centers, NGOs, and international pharmaceutical distributors worldwide.

Valstead 450mg Tablets
Composition: Valganciclovir Hydrochloride 450mg Tablet
International Trade Name: Valcyte®

Valstead 450 is a high-quality Valganciclovir 450mg Tablet, a bioequivalent formulation of the internationally recognized antiviral medicine marketed under the brand name Valcyte®. Manufactured in WHO-GMP certified pharmaceutical facilities, Valstead Tablets are supplied by trusted pharmaceutical exporters from India to support advanced antiviral therapy programs, particularly in transplant medicine and immunocompromised patient care.

Valganciclovir is an oral prodrug of ganciclovir that is rapidly converted in the body to its active form, effectively inhibiting viral DNA synthesis and preventing viral replication. Valstead 450mg Tablets are primarily indicated for the treatment and prevention of cytomegalovirus (CMV) infections, including CMV retinitis in patients with AIDS, and CMV prophylaxis in solid organ and hematopoietic stem cell transplant recipients, in accordance with established clinical guidelines.

Valganciclovir 450mg tablets, Valstead 450 tablet, Valcyte generic, CMV treatment medicine, antiviral tablets for transplant patients, CMV prophylaxis drug, pharmaceutical exporter India, and antiviral manufacturer India.

Valstead 450mg Tablets are manufactured under stringent GMP and pharmaceutical quality standards, ensuring consistent potency, safety, and therapeutic efficacy. The tablets are supplied in export-grade, tamper-proof packaging with complete regulatory and quality documentation, making them suitable for transplant centers, tertiary care hospitals, infectious disease clinics, government healthcare programs, and international pharmaceutical distributors worldwide.

Vagacyte 450mg Tablets
Composition: Valganciclovir Tablets USP 450mg
International Trade Name: Valcyte®

Vagacyte 450 is a high-quality Valganciclovir 450mg Tablet, a bioequivalent formulation of the internationally recognized antiviral medicine marketed under the brand name Valcyte®. Manufactured in WHO-GMP certified pharmaceutical facilities, Vagacyte Tablets are supplied by trusted pharmaceutical exporters from India to support advanced antiviral therapy programs, particularly in transplant medicine and immunocompromised patient care.

Valganciclovir is an oral prodrug of ganciclovir that is rapidly converted in the body to its active form, effectively inhibiting viral DNA synthesis and preventing viral replication. Vagacyte 450mg Tablets are primarily indicated for the treatment and prevention of cytomegalovirus (CMV) infections, including CMV retinitis in patients with AIDS, and CMV prophylaxis in solid organ and hematopoietic stem cell transplant recipients, in accordance with established clinical guidelines.

Valganciclovir 450mg tablets, Vagacyte 450 tablet, Valcyte generic, CMV treatment medicine, antiviral tablets for transplant patients, CMV prophylaxis drug, pharmaceutical exporter India, and antiviral manufacturer India.

Vagacyte 450mg Tablets are manufactured under stringent GMP and pharmaceutical quality standards, ensuring consistent potency, safety, and therapeutic efficacy. The tablets are supplied in export-grade, tamper-proof packaging with complete regulatory and quality documentation, making them suitable for transplant centers, tertiary care hospitals, infectious disease clinics, government healthcare programs, and international pharmaceutical distributors worldwide.

Yaz Tablets
Composition: Ethinyl Estradiol + Drospirenone
International Trade Name: Yasmin®

Yaz Tablets are a high-quality combined oral contraceptive containing Ethinyl Estradiol and Drospirenone, therapeutically equivalent to the internationally recognized brand Yasmin®. Manufactured in WHO-GMP certified facilities, Yaz Tablets are supplied by trusted pharmaceutical exporters from India to support advanced global women’s health and reproductive care programs, particularly in effective contraception, cycle regulation, and management of hormonal disorders such as premenstrual dysphoric disorder (PMDD) and acne.

This combination delivers Ethinyl Estradiol, a synthetic estrogen, together with Drospirenone, a progestin with anti-androgenic and anti-mineralocorticoid properties, providing reliable contraception while also helping to reduce water retention, bloating, acne, and hormonal fluctuations. Yaz Tablets are primarily indicated for prevention of pregnancy, management of moderate acne vulgaris in women seeking oral contraception, and treatment of premenstrual dysphoric disorder (PMDD).

Ethinyl Estradiol + Drospirenone tablets, Yaz tablets, Yasmin generic, oral contraceptive price, combined hormonal contraceptive, women’s health tablets, anti-acne oral therapy, hormonal therapy exporter India, and oral contraceptive manufacturer India.

Yaz Tablets are manufactured under stringent GMP and pharmaceutical quality standards, ensuring consistent efficacy, safety, and patient tolerability. The tablets are supplied in secure, tamper-proof, export-grade blister packaging with complete regulatory documentation, making them suitable for gynecology clinics, hospitals, pharmacies, government reproductive health programs, and international pharmaceutical distributors.

Hivus-LR Tablets
Composition: Lopinavir & Ritonavir Tablets
International Trade Name: Kaletra®

Hivus-LR is a high-quality fixed-dose combination tablet of Lopinavir and Ritonavir, a bioequivalent formulation of the internationally recognized antiretroviral medicine marketed under the brand name Kaletra®. Manufactured in WHO-GMP certified pharmaceutical facilities, Hivus-LR Tablets are supplied by trusted pharmaceutical exporters from India to support global HIV/AIDS treatment programs, providing an effective protease inhibitor–based therapy for adults and adolescents living with HIV-1.

Lopinavir is a protease inhibitor (PI) that inhibits HIV protease, preventing viral maturation and reducing viral replication. Ritonavir acts as a pharmacokinetic booster by inhibiting CYP3A enzymes, increasing Lopinavir plasma levels and prolonging its therapeutic effect. Hivus-LR Tablets are primarily indicated for the treatment of HIV-1 infection in combination with other antiretroviral agents, following national and international HIV treatment guidelines.

Lopinavir Ritonavir tablets, Hivus-LR tablet, Kaletra generic, HIV protease inhibitor therapy, boosted PI regimen, antiretroviral medicine, pharmaceutical exporter India, and antiretroviral manufacturer India.

Hivus-LR Tablets are manufactured under stringent GMP and pharmaceutical quality standards, ensuring consistent potency, safety, and therapeutic efficacy. The tablets are supplied in secure, export-grade, tamper-proof packaging with complete regulatory and quality documentation, making them suitable for government HIV programs, hospitals, ART centers, NGOs, and international pharmaceutical distributors worldwide.

Anzavir-R Tablets
Composition: Atazanavir Sulphate & Ritonavir Tablets
International Trade Name: Reyataz® / Anzavir-R

Anzavir-R is a high-quality fixed-dose combination tablet of Atazanavir Sulphate and Ritonavir, a bioequivalent formulation of the internationally recognized antiretroviral medicines Reyataz® (Atazanavir). Manufactured in WHO-GMP certified pharmaceutical facilities, Anzavir-R Tablets are supplied by trusted pharmaceutical exporters from India to support global HIV/AIDS treatment programs, providing an effective protease inhibitor–based therapy for adults and adolescents living with HIV-1.

Atazanavir Sulphate is a protease inhibitor (PI) that inhibits HIV protease, preventing viral maturation and reducing viral replication. Ritonavir acts as a pharmacokinetic booster by inhibiting CYP3A enzymes, increasing Atazanavir plasma levels and prolonging its therapeutic effect. Anzavir-R Tablets are primarily indicated for the treatment of HIV-1 infection in combination with other antiretroviral agents, following national and international HIV treatment guidelines.

Atazanavir Ritonavir tablets, Anzavir-R tablet, Reyataz generic, boosted protease inhibitor therapy, HIV protease inhibitor regimen, antiretroviral medicine, pharmaceutical exporter India, and antiretroviral manufacturer India.

Anzavir-R Tablets are manufactured under stringent GMP and pharmaceutical quality standards, ensuring consistent potency, safety, and therapeutic efficacy. The tablets are supplied in secure, export-grade, tamper-proof packaging with complete regulatory and quality documentation, making them suitable for government HIV programs, hospitals, ART centers, NGOs, and international pharmaceutical distributors worldwide.

Abec-L Tablets
Composition: Abacavir & Lamivudine Tablets
International Trade Name: Epivir®

Abec-L is a high-quality fixed-dose combination of Abacavir and Lamivudine, a bioequivalent formulation of the internationally recognized antiretroviral medicine Epivir® (Lamivudine). Manufactured in WHO-GMP certified pharmaceutical facilities, Abec-L Tablets are supplied by trusted pharmaceutical exporters from India to support global HIV/AIDS treatment programs, providing a convenient and effective once-daily regimen that improves adherence and long-term treatment outcomes.

This combination includes Abacavir and Lamivudine, both nucleoside reverse transcriptase inhibitors (NRTIs), which work by inhibiting HIV reverse transcriptase, preventing viral replication. Abec-L Tablets are primarily indicated for the treatment of HIV-1 infection in adults and adolescents, as part of combination antiretroviral therapy (ART) in accordance with national and international HIV treatment guidelines.

Abacavir Lamivudine tablets, Abec-L tablet, Epivir generic, fixed-dose combination ART, HIV single-tablet regimen, NRTI antiretroviral therapy, pharmaceutical exporter India, and antiretroviral manufacturer India.

Abec-L Tablets are manufactured under stringent GMP and pharmaceutical quality standards, ensuring consistent potency, safety, and therapeutic efficacy. The tablets are supplied in secure, export-grade, tamper-proof packaging with complete regulatory and quality documentation, making them suitable for government HIV programs, hospitals, ART centers, NGOs, and international pharmaceutical distributors worldwide.

Abacavex-L Tablets
Composition: Abacavir & Lamivudine Tablets
International Trade Name: Kivexa®

Abacavex-L is a high-quality fixed-dose combination of Abacavir and Lamivudine, a bioequivalent formulation of the internationally recognized antiretroviral medicine marketed under the brand name Kivexa®. Manufactured in WHO-GMP certified pharmaceutical facilities, Abacavex-L Tablets are supplied by trusted pharmaceutical exporters from India to support global HIV/AIDS treatment programs, offering a convenient once-daily regimen that improves adherence and long-term treatment outcomes.

This combination includes Abacavir and Lamivudine, both nucleoside reverse transcriptase inhibitors (NRTIs), which work by inhibiting the HIV reverse transcriptase enzyme, thereby preventing viral replication. Abacavex-L Tablets are primarily indicated for the treatment of HIV-1 infection in adults and adolescents, as part of combination antiretroviral therapy (ART) in line with national and international HIV treatment guidelines.

Abacavir Lamivudine tablets, Abacavex-L tablet, Kivexa generic, fixed-dose combination ART, HIV single-tablet regimen, NRTI antiretroviral therapy, pharmaceutical exporter India, and antiretroviral manufacturer India.

Abacavex-L Tablets are manufactured under stringent GMP and pharmaceutical quality standards, ensuring consistent potency, safety, and therapeutic efficacy. The tablets are supplied in export-grade, tamper-proof packaging with complete regulatory and quality documentation, making them suitable for government HIV programs, hospitals, ART centers, NGOs, and international pharmaceutical distributors worldwide.